Moore Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Buy |
290,000
+50,000
| +21% | +$1.82M | 0.13% | 107 |
|
|
2025
Q1 | $8.69M | Sell |
240,000
-5,000
| -2% | -$181K | 0.18% | 94 |
|
|
2024
Q4 | $10.3M | Hold |
245,000
| – | – | 0.12% | 116 |
|
|
2024
Q3 | $13.6M | Hold |
245,000
| – | – | 0.25% | 84 |
|
|
2024
Q2 | $10.1M | Buy |
245,000
+60,000
| +32% | +$2.47M | 0.17% | 112 |
|
|
2024
Q1 | $8.64M | Hold |
185,000
| – | – | 0.14% | 114 |
|
|
2023
Q4 | $8.85M | Buy |
185,000
+35,000
| +23% | +$1.67M | 0.15% | 90 |
|
|
2023
Q3 | $5.35M | Buy |
150,000
+45,000
| +43% | +$1.6M | 0.1% | 119 |
|
|
2023
Q2 | $4.84M | Buy |
105,000
+75,000
| +250% | +$3.46M | 0.08% | 150 |
|
|
2023
Q1 | $1.2M | Buy |
+30,000
| New | +$1.2M | 0.03% | 255 |
|
|
2016
Q1 | – | Sell |
-32,000
| Closed | -$3.59M | – | 307 |
|
|
2015
Q4 | $3.59M | Buy |
+32,000
| New | +$3.59M | 0.11% | 143 |
|
|
2015
Q2 | – | Sell |
-35,000
| Closed | -$2.17M | – | 449 |
|
|
2015
Q1 | $2.17M | Buy |
+35,000
| New | +$2.17M | 0.05% | 208 |
|